{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:29:32Z","timestamp":1758266972796,"version":"3.40.3"},"publisher-location":"Cham","reference-count":31,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319102498"},{"type":"electronic","value":"9783319102504"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/5584_2014_87","type":"book-chapter","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T10:14:13Z","timestamp":1413195253000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Markers of Bone Metabolism in Children with Nephrotic Syndrome Treated with Corticosteroids"],"prefix":"10.1007","author":[{"given":"Ma\u0142gorzata","family":"Pa\u0144czyk-Tomaszewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Adamczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Kisiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Skrzypczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Przedlacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Stelmaszczyk-Emmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Demkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Roszkowska-Blaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"87_CR1","first-page":"257","volume":"6","author":"J Ambroszkiewicz","year":"2002","unstructured":"Ambroszkiewicz J, Gajewska J, Laskowska-Klita T (2002) Serum osteocalcin and bone alkaline phosphatase in relation to age and gender. Med Wieku Rozwoj 6:257\u2013265","journal-title":"Med Wieku Rozwoj"},{"key":"87_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00198-011-1659-1","volume":"64","author":"A Arabi","year":"2012","unstructured":"Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G (2012) PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int 64:971\u2013980","journal-title":"Osteoporos Int"},{"key":"87_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00467-005-2118-z","volume":"21","author":"M Bak","year":"2006","unstructured":"Bak M, Serdaroglu E, Guclu R (2006) Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol 21:350\u2013354","journal-title":"Pediatr Nephrol"},{"key":"87_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00467-004-1537-6","volume":"19","author":"NK Biyikli","year":"2004","unstructured":"Biyikli NK, Emre S, Sirin A, Bilge I (2004) Biochemical bone markers in nephrotic children. Pediatr Nephrol 19:869\u2013873","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 5","key":"87_CR5","first-page":"1341","volume":"15","author":"E Canalis","year":"2002","unstructured":"Canalis E, Pereira RC, Delany AM (2002) Effects of glucocorticoids on the skeleton. J Pediatr Endocrinol Metab 15(Suppl 5):1341\u20131345","journal-title":"J Pediatr Endocrinol Metab"},{"key":"87_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazzioti G, Giustina A, Bilezikian JP (2007) Glucocorticoid\u2013induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319\u20131328","journal-title":"Osteoporos Int"},{"key":"87_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/CCLM.2010.019","volume":"48","author":"E Cavalier","year":"2010","unstructured":"Cavalier E, Rozet E, Carlisi A, Bekaert AC, Rousselle O, Hubert P, Chapelle JP, Delanaye P (2010) Analytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison. Clin Chem Lab Med 48:67\u201372","journal-title":"Clin Chem Lab Med"},{"key":"87_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bone.2013.01.040","volume":"54","author":"V Csakvary","year":"2013","unstructured":"Csakvary V, Puskas T, Oroszlan G, Lakatos P, Kalman B, Kovacs GL, Toldy E (2013) Hormonal and biochemical parameters correlated with bone densitometric markers in prepubertal Hungarian children. Bone 54:106\u2013112","journal-title":"Bone"},{"key":"87_CR9","first-page":"1146","volume":"74","author":"B Demiaux","year":"1992","unstructured":"Demiaux B, Arlot ME, Chapuy MC, Meunier PJ, Delmas PD (1992) Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab 74:1146\u20131151","journal-title":"J Clin Endocrinol Metab"},{"key":"87_CR10","first-page":"130","volume":"28","author":"A Dobrza\u0144ska","year":"2010","unstructured":"Dobrza\u0144ska A, Charzewska J, Chlebna-Sok\u00f3\u0142 D, Chybicka A, Czech-Kowalska J, Helwich E, Imiela JR, Karczmarewicz E, Ksi\u0105\u017cyk JB, Lewi\u0144ski A, Lorenc RS, Lukas W, \u0141ukaszkiewicz J, Marcinowska-Suchowierska E, Milanowski A, Milewicz A, P\u0142udowski P, Pronicka E, Radowicki S, Ry\u017cko J, Socha J, Szczapa J, Weker H (2010) Prophylaxis of vitamin D deficiency \u2013 Polish recommendations 2009. Pol Merkur Lekarski 28:130\u2013133","journal-title":"Pol Merkur Lekarski"},{"key":"87_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1017\/S002966510800699X","volume":"67","author":"R Eastell","year":"2008","unstructured":"Eastell R, Hannon RA (2008) Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc 67:157\u2013162","journal-title":"Proc Nutr Soc"},{"key":"87_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00198-011-1621-2","volume":"23","author":"J Feber","year":"2012","unstructured":"Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, Blydt-Hansen T, Clarson C, Filler G, Hay J, Hebert D, Lentle B, Matzinger M, Midgley J, Moher D, Pinsk M, Rauch F, Rodd C, Shenouda N, Siminoski K, Ward LM, Canadian STOPP Consortium (2012) Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int 23:751\u2013760","journal-title":"Osteoporos Int"},{"key":"87_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00467-003-1378-8","volume":"19","author":"M Freundlich","year":"2004","unstructured":"Freundlich M, Jofe M, Goodman WG, Salusky IB (2004) Bone histology in steroid-treated children with non-azotemic nephrotic syndrome. Pediatr Nephrol 19:400\u2013407","journal-title":"Pediatr Nephrol"},{"key":"87_CR14","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1210\/jc.2013-2198","volume":"98","author":"A Fujiyoshi","year":"2013","unstructured":"Fujiyoshi A, Polgreen LE, Hurley DL, Gross MD, Sidney S, Jacobs DR Jr (2013) A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: the CARDIA study. J Clin Endocrinol Metab 98:4038\u20134046","journal-title":"J Clin Endocrinol Metab"},{"key":"87_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0272-6386(03)00348-2","volume":"41","author":"S Gulati","year":"2003","unstructured":"Gulati S, Godbole M, Singh U, Gulati K, Srivastava A (2003) Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis 41:1163\u20131169","journal-title":"Am J Kidney Dis"},{"key":"87_CR16","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/ndt\/gfh809","volume":"20","author":"S Gulati","year":"2005","unstructured":"Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A (2005) Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant 20:1598\u20131603","journal-title":"Nephrol Dial Transplant"},{"doi-asserted-by":"crossref","unstructured":"Hidalgo AA, Trump DL, Johnson CS (2010) Glucocorti-coid regulation of the vitamin D receptor. J Steroid Biochem Mol Biol 121:372\u2013375","key":"87_CR32","DOI":"10.1016\/j.jsbmb.2010.03.081"},{"key":"87_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00467-008-1073-x","volume":"25","author":"B Hoppe","year":"2010","unstructured":"Hoppe B, Kemper MJ (2010) Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol 25:403\u2013413","journal-title":"Pediatr Nephrol"},{"key":"87_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ki.1978.23","volume":"13","author":"ISKDC \u2013 A report of the International Study of Kidney Disease in Children","year":"1978","unstructured":"ISKDC \u2013 A report of the International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159\u2013165","journal-title":"Kidney Int"},{"key":"87_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/kisup.2012.16","volume":"2","author":"KDIGO Clinical Practice Guideline for Glomerulonephritis","year":"2012","unstructured":"KDIGO Clinical Practice Guideline for Glomerulonephritis (2012) Chapter 3: steroid-sensitive nephrotic syndrome in children. Kidney Int Supp 2:163\u2013171","journal-title":"Kidney Int Supp"},{"key":"87_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/bmj.305.6848.273","volume":"305","author":"KT Khaw","year":"1992","unstructured":"Khaw KT, Sneyd MJ, Compston J (1992) Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. Br Med J 305:273\u2013277","journal-title":"Br Med J"},{"key":"87_CR22","first-page":"627","volume":"61","author":"C Ko\u015fan","year":"2012","unstructured":"Ko\u015fan C, Ayar G, Orbak Z (2012) Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome. West Indian Med J 61:627\u2013630","journal-title":"West Indian Med J"},{"key":"87_CR23","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/art.1780331005","volume":"33","author":"MA Kotowicz","year":"1990","unstructured":"Kotowicz MA, Hall S, Hunder GG, Cedel SL, Mann KG, Riggs BL (1990) Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum 33:1487\u20131492","journal-title":"Arthritis Rheum"},{"key":"87_CR24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJMoa040367","volume":"351","author":"MB Leonard","year":"2004","unstructured":"Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long \u2013term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351:868\u2013875","journal-title":"N Engl J Med"},{"key":"87_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/BF00869084","volume":"8","author":"B Lettgen","year":"1994","unstructured":"Lettgen B, Jeken C, Reiners C (1994) Influence of steroids medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 8:667\u2013670","journal-title":"Pediatr Nephrol"},{"key":"87_CR26","first-page":"1237","volume":"76","author":"OP Mishra","year":"2009","unstructured":"Mishra OP, Meena SK, Singh SK, Prasad R, Mishra RN (2009) Bone mineral density in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 76:1237\u20131239","journal-title":"Pediatr Nephrol"},{"key":"87_CR27","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1359\/jbmr.2000.15.7.1398","volume":"15","author":"A Rogers","year":"2000","unstructured":"Rogers A, Hannon RA, Eastell R (2000) Biochemical markers as predictors of rates of bone loss after menopause. J Bone Mineral Res 15:1398\u20131404","journal-title":"J Bone Mineral Res"},{"key":"87_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","volume":"13","author":"PD Ross","year":"1998","unstructured":"Ross PD, Knowlton W (1998) Rapid bone loss is associated with increased levels of biochemical markers. J Bone Mineral Res 13:297\u2013302","journal-title":"J Bone Mineral Res"},{"key":"87_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0889-8529(02)00064-6","volume":"32","author":"KG Saag","year":"2003","unstructured":"Saag KG (2003) Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am 32:135\u2013157","journal-title":"Endocrinol Metab Clin North Am"},{"key":"87_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S8756-3282(02)00742-1","volume":"30","author":"N Sasaki","year":"2002","unstructured":"Sasaki N, Kusano E, And oY, Nemoto J, Iimura O, Ito C, Takeda S, Yano K, Tsuda E, Asano Y (2002) Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. Bone 30:653\u2013658","journal-title":"Bone"},{"key":"87_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2478\/v10039-012-0016-8","volume":"57","author":"M Zaniew","year":"2012","unstructured":"Zaniew M, Jarmolinski T (2012) Vitamin D status and bone density in steroid-treated children with glomerulopathies: effect of cholecalciferol and calcium supplementation. Adv Med Sci 57:88\u201393","journal-title":"Adv Med Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Body Metabolism and Exercise"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2014_87","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T09:53:05Z","timestamp":1674899585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/5584_2014_87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319102498","9783319102504"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/5584_2014_87","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"14 October 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}